Cerberus Capital Management is weighing a sale of Covis Pharma Holdings Sarl, which could fetch about $800 million, Bloomberg reported. Covis, a specialty pharmaceutical company, has attracted attention from private equity, the story said.
Cerberus Capital Management is weighing a sale of Covis Pharma Holdings Sarl, which could fetch about $800 million, Bloomberg reported. Covis, a specialty pharmaceutical company, has attracted attention from private equity, the story said.
Copyright PEI Media
Not for publication, email or dissemination
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.